Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor Degrader
Lawrence B. Snyder(Arvinas (United States)), John Houston(Arvinas (United States))
Cited by 66
Related Papers
No related papers found
Powered by citation graph analysis